Is age alone a contraindication to major cancer surgery?

Area of Science:

• Surgical Oncology
• Geriatric Medicine
• Oncology

Background:

• The global population is aging, increasing the number of elderly patients requiring major cancer operations.
• Assessing the benefits and risks of extensive surgical interventions in older adults is crucial.

Purpose of the Study:

• To evaluate the safety and efficacy of major cancer surgeries in elderly patients across different age brackets.
• To identify factors influencing operative mortality and patient outcomes.

Main Methods:

• A retrospective analysis of 268 elderly patients (65-92 years) who underwent major surgery for various cancers (esophageal, gastric, intestinal, pancreatic, retroperitoneal) between 1978 and 1983.
• Patients were stratified into three age groups: 65-74, 75-84, and 85-92 years.
• Operative mortality rates were analyzed, considering preoperative cardiopulmonary disease and postoperative complications.

Main Results:

• Overall operative mortality was 11.2%, with higher rates in older groups (20.8% in 85-92 years).
• Preoperative cardiopulmonary disease and postoperative complications were key factors in mortality.
• After accounting for these factors, mortality rates were comparable across age groups (6.1% to 8.3%).
• Most patients experienced significant symptom palliation with acceptable hospital stays.

Conclusions:

• Major cancer surgery can be safely performed in elderly patients, offering substantial benefits.
• Optimizing preoperative patient status and intensifying postoperative care are critical for improving surgical outcomes in this population.
• Tailoring surgical approach to the minimum effective intervention is recommended.